Position statement on bioresorbable vascular scaffolds in Portugal

• Autor(a) principal: Teles, R.
• Data de Publicação: 2013
• Outros Autores: Pereira, H., Cyrne-Carvalho, H., Patrício, L., Santos, R., Baptista, J., Pipa, J., Farto-Abreu, P., Faria, H., Ramos, S., Gama-Ribeiro, V., Martins, D., Almeida, M.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.16/1721
• topic: Angioplastia coronária; Bioersorbable vascular scaffolds; Coronary angioplasty; Diabetes; Diabetic; Intervenção coronária percutânea; Percutaneous coronary intervention; Stent; Suportes vasculares restaurativos transitórios

BACKGROUND: Bioresorbable vascular scaffolds (BVS) were recently approved for percutaneous coronary intervention in Europe. The aim of this position statement is to review the information and studies on available BVS, to stimulate discussion on their use and to propose guidelines for this treatment option in Portugal. METHODS AND RESULTS: A working group was set up to reach a consensus based on current evidence, discussion of clinical case models and individual experience. The evidence suggests that currently available BVS can produce physiological and clinical improvements in selected patients. There are encouraging data on their durability and long-term safety. Initial indications were grouped into three categories: (a) consensual and appropriate - young patients, diabetic patients, left anterior descending artery, long lesions, diffuse disease, and hybrid strategy; (b) less consensual but possible - small collateral branches, stabilized acute coronary syndromes; and (c) inappropriate - left main disease, tortuosity, severe calcification. CONCLUSION: BVS are a viable treatment option based on the encouraging evidence of their applicability and physiological and clinical results. They should be used in appropriate indications and will require technical adaptations. Outcome monitoring and evaluation is essential to avoid inappropriate use. It is recommended that medical societies produce clinical guidelines based on high-quality registries as soon as possible.